Common Stock and Stock-Based Compensation - Narrative (Details)		3 Months Ended	6 Months Ended		12 Months Ended	83 Months Ended
	Sep. 24, 2020 USD ($) $ / shares shares	Mar. 31, 2023 $ / shares shares	Jun. 30, 2023 USD ($) commonStock shares	Jun. 30, 2022 USD ($) shares	Dec. 31, 2020 USD ($)	Jun. 30, 2023 USD ($) commonStock shares	Sep. 23, 2020 USD ($)	Mar. 31, 2020 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payments to repurchase stock			$ 0	$ 8,053,000
Award vesting period			4 years
Number of share of common stock holder has a right to | commonStock			1			1
Volatility			44.31%	46.88%
Expected term (in years)			5 years 7 months 2 days	5 years 7 months 24 days
Expected dividend yield			0.00%	0.00%
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares			211,800	228,200
Risk-free interest rate		4.39%
Volatility		44.00%
Expected term (in years)		4 years
Expected dividend yield		0.00%
S&P Biotechnology | PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares		211,800
S&P Biotechnology | PSUs | Other Executives
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares		$ 41.72
March 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount								$ 160,000,000
Accelerated share repurchases, authorized amount							$ 25,000,000
Accelerated share repurchases, payment	$ 25,000,000
Accelerated share repurchases, shares received (in shares) | shares	550,623
Accelerated share repurchases, initial price paid per share (in dollars per share) | $ / shares	$ 45.40
Fair value adjustments related to derivative instruments					$ 3,000,000
Share Repurchase Programs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock repurchased (in shares) | shares						4,552,730
Payments to repurchase stock						$ 246,100,000